Adamis Pharmaceuticals Corp 4
4 · Adamis Pharmaceuticals Corp · Filed Feb 12, 2015
Insider Transaction Report
Form 4
Rahman Ahmed Shayan Fazlur
10% Owner
Transactions
- Sale
Common Stock, par value $0.0001
2015-02-11$6.40/sh−10,000$64,000→ 1,670,388 total(indirect: See Footnote) - Sale
Common Stock, par value $0.0001
2015-02-12$6.40/sh−23,000$147,223→ 1,647,388 total(indirect: See Footnote) - Sale
Common Stock, par value $0.0001
2015-02-10$6.39/sh−5,000$31,945→ 1,680,388 total(indirect: See Footnote)
Footnotes (3)
- [F1]Represents the sale of 5,000 shares in 2 separate transactions, ranging from $6.370 to $6.500 per share, resulting in a weighted average sale price per share of $6.389. The Reporting Persons undertake to provide upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F2]Represents shares of the Issuer's common stock held by Eses Holdings (FZE), a corporation organized under the laws of Sharjah, United Arab Emirates ("Eses"). Ahmed Shayan Fazlur Rahman is the sole shareholder of Eses, and possesses the power to vote and the power to direct the disposition of all securities of the Issuer held by Eses.
- [F3]Represents the sale of 23,000 shares in 3 separate transactions, ranging from $6.400 to $6.402 per share, resulting in a weighted average sale price per share of $6.401. The Reporting Persons undertake to provide upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.